Background The unresolved COVID‐19 pandemic considerably impacts the health services
in Iraq and worldwide. Consecutive waves of mutated virus increased virus spread and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy …

Introduction. Health care workers have had a challenging task since the COVID‐19
outbreak. Prompt and effective predictors of clinical outcomes are crucial to recognize …

Introduction. Mortality among critically ill COVID‐19 patients remains relatively high despite
different potential therapeutic modalities being introduced recently. The treatment of critically …

Tocilizumab is an interleukin (IL)‐6 receptor inhibitor that has been proposed as a
therapeutic agent for treating coronavirus disease 2019 (COVID‐19). The aim of this …

Considering the high impact that severe Coronavirus disease 2019 (COVID-19) cases still
pose on public health and their complex pharmacological management, the search for new …

Introduction In the current COVID-19 pandemic, clinicians require a manageable set of
decisive parameters that can be used to (i) rapidly identify SARS-CoV-2 positive patients,(ii) …

Covid-19 still remains as global pandemic surging with different variants like alpha, beta,
gamma, delta and most omicronin various countries resulted into SARS-CoV-2. An …

Introduction Coronavirus disease 2019 (COVID-19) has become the worst catastrophe of the
twenty-first century and has led to the death of more than 6.9 million individuals across the …

Background The shock index (SI) ratio serves as a straightforward predictor to identify
patients who are either at risk of or experiencing shock. COVID-19 patients with shock face …